Read our information page on mTOR inhibitor medicines used in TSC Ava’s experience with mTOR inhibitors Joelle, Ava’s Mum, Western Australia Ava is ten and has tuberous sclerosis complex (TSC). She loves gymnastics, drama and horse riding and is generally … Read More
The DermNet NZ presents authoritative facts about the skin for consumers and health professionals in New Zealand and throughout the world. It is written and reviewed by dermatologists, other health professionals and medical writers. Access to DermNet NZ is free … Read More
Dr David Mowat, Clinical Geneticist at Sydney Children’s Hospital, speaks about the ways that TSC affects the skin and about research into topical mTOR inhibitor cream. Watch this video directly on YouTube
A follow up publication regarding the group of patients being treated with topical rapamycin in Perth, Western Australia has been published. Tu, J., et al., Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: follow up of a pilot … Read More
Foster, R. S., Bint, L. J. and Halbert, A. R. (2012), Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: A pilot study of four patients. Australasian Journal of Dermatology, 53: 52–56. doi: 10.1111/j.1440-0960.2011.00837.x This article reports on … Read More
The Australasian College of Dermatologists is the medical college responsible for the training and professional development of medical practitioners in the specialty of dermatology. Their website includes the ability to search for a dermatologist in your local area.